Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 113 entries
Sorted by: Best Match Show Resources per page
Airway observations during upper endoscopy predicting obstructive sleep apnea.

Annals of gastroenterology

Harvin G, Ali E, Raina A, Leland W, Abid S, Vahora Z, Movahed H, Kachru S, Tee R.
PMID: 27708514
Ann Gastroenterol. 2016 Oct-Dec;29(4):481-486. doi: 10.20524/aog.2016.0054. Epub 2016 Jun 10.

BACKGROUND: This pilot study examined airway characteristics during upper endoscopy to determine who is at high risk for obstructive sleep apnea.METHODS: Patients undergoing routine upper endoscopy were divided into 2 groups according to the Berlin Questionnaire (high and low...

Cite
Harvin G, Ali E, Raina A, et al. Airway observations during upper endoscopy predicting obstructive sleep apnea. Ann Gastroenterol. 2016;29(4):481-486doi: 10.20524/aog.2016.0054.
Harvin, G., Ali, E., Raina, A., Leland, W., Abid, S., Vahora, Z., Movahed, H., Kachru, S., & Tee, R. (2016). Airway observations during upper endoscopy predicting obstructive sleep apnea. Annals of gastroenterology, 29(4), 481-486. https://doi.org/10.20524/aog.2016.0054
Harvin, Glenn, et al. "Airway observations during upper endoscopy predicting obstructive sleep apnea." Annals of gastroenterology vol. 29,4 (2016): 481-486. doi: https://doi.org/10.20524/aog.2016.0054
Harvin G, Ali E, Raina A, Leland W, Abid S, Vahora Z, Movahed H, Kachru S, Tee R. Airway observations during upper endoscopy predicting obstructive sleep apnea. Ann Gastroenterol. 2016 Oct-Dec;29(4):481-486. doi: 10.20524/aog.2016.0054. Epub 2016 Jun 10. PMID: 27708514; PMCID: PMC5049555.
Copy Download .nbib Format: NLM
Could a healthy ego identity serve as a protective factor against suicidal tendencies? A pilot study.

Journal of child and adolescent mental health

Ramgoon S, Bachoo S, Patel C, Paruk Z.
PMID: 25865205
J Child Adolesc Ment Health. 2006 Oct;18(2):49-54. doi: 10.2989/17280580609486623.

OBJECTIVE: The study investigated the interrelationship between adolescent ego identity, suicidal tendencies, gender and race in a sample of South African Indian and Black secondary school students.METHOD: The Ego Identity Scale (EIS) and the Multi-attitude Suicide Tendency Scale (MAST)...

Cite
Ramgoon S, Bachoo S, Patel C, et al. Could a healthy ego identity serve as a protective factor against suicidal tendencies? A pilot study. J Child Adolesc Ment Health. 2006;18(2):49-54doi: 10.2989/17280580609486623.
Ramgoon, S., Bachoo, S., Patel, C., & Paruk, Z. (2006). Could a healthy ego identity serve as a protective factor against suicidal tendencies? A pilot study. Journal of child and adolescent mental health, 18(2), 49-54. https://doi.org/10.2989/17280580609486623
Ramgoon, Sarojini, et al. "Could a healthy ego identity serve as a protective factor against suicidal tendencies? A pilot study." Journal of child and adolescent mental health vol. 18,2 (2006): 49-54. doi: https://doi.org/10.2989/17280580609486623
Ramgoon S, Bachoo S, Patel C, Paruk Z. Could a healthy ego identity serve as a protective factor against suicidal tendencies? A pilot study. J Child Adolesc Ment Health. 2006 Oct;18(2):49-54. doi: 10.2989/17280580609486623. PMID: 25865205.
Copy Download .nbib Format: NLM
Enhanced Disease Susceptibility1 Mediates Pathogen Resistance and Virulence Function of a Bacterial Effector in Soybean.

Plant physiology

Wang J, Shine MB, Gao QM, Navarre D, Jiang W, Liu C, Chen Q, Hu G, Kachroo A.
PMID: 24872380
Plant Physiol. 2014 Jul;165(3):1269-1284. doi: 10.1104/pp.114.242495. Epub 2014 May 28.

Enhanced disease susceptibility1 (EDS1) and phytoalexin deficient4 (PAD4) are well-known regulators of both basal and resistance (R) protein-mediated plant defense. We identified two EDS1-like (GmEDS1a/GmEDS1b) proteins and one PAD4-like (GmPAD4) protein that are required for resistance signaling in soybean...

Cite
Wang J, Shine MB, Gao QM, et al. Enhanced Disease Susceptibility1 Mediates Pathogen Resistance and Virulence Function of a Bacterial Effector in Soybean. Plant Physiol. 2014;165(3):1269-1284doi: 10.1104/pp.114.242495.
Wang, J., Shine, M. B., Gao, Q. M., Navarre, D., Jiang, W., Liu, C., Chen, Q., Hu, G., & Kachroo, A. (2014). Enhanced Disease Susceptibility1 Mediates Pathogen Resistance and Virulence Function of a Bacterial Effector in Soybean. Plant physiology, 165(3), 1269-1284. https://doi.org/10.1104/pp.114.242495
Wang, Jialin, et al. "Enhanced Disease Susceptibility1 Mediates Pathogen Resistance and Virulence Function of a Bacterial Effector in Soybean." Plant physiology vol. 165,3 (2014): 1269-1284. doi: https://doi.org/10.1104/pp.114.242495
Wang J, Shine MB, Gao QM, Navarre D, Jiang W, Liu C, Chen Q, Hu G, Kachroo A. Enhanced Disease Susceptibility1 Mediates Pathogen Resistance and Virulence Function of a Bacterial Effector in Soybean. Plant Physiol. 2014 Jul;165(3):1269-1284. doi: 10.1104/pp.114.242495. Epub 2014 May 28. PMID: 24872380; PMCID: PMC4081336.
Copy Download .nbib Format: NLM
Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis.

Patient preference and adherence

Svedbom A, Storck C, Kachroo S, Govoni M, Khalifa A.
PMID: 28435230
Patient Prefer Adherence. 2017 Apr 07;11:719-729. doi: 10.2147/PPA.S128665. eCollection 2017.

PURPOSE: In immune-mediated rheumatic diseases (IMRDs), persistence to treatment may be used as a surrogate marker for long-term treatment success. In previous comparisons of persistence to tumor necrosis factor α inhibitors (TNFis), a paucity of data for subcutaneous (SC)...

Cite
Svedbom A, Storck C, Kachroo S, et al. Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Patient Prefer Adherence. 2017;11:719-729doi: 10.2147/PPA.S128665.
Svedbom, A., Storck, C., Kachroo, S., Govoni, M., & Khalifa, A. (2017). Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Patient preference and adherence, 11719-729. https://doi.org/10.2147/PPA.S128665
Svedbom, Axel, et al. "Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis." Patient preference and adherence vol. 11 (2017): 719-729. doi: https://doi.org/10.2147/PPA.S128665
Svedbom A, Storck C, Kachroo S, Govoni M, Khalifa A. Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Patient Prefer Adherence. 2017 Apr 07;11:719-729. doi: 10.2147/PPA.S128665. eCollection 2017. PMID: 28435230; PMCID: PMC5391163.
Copy Download .nbib Format: NLM
Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes.

BMJ open diabetes research & care

LeBlanc ES, Rosales AG, Kachroo S, Mukherjee J, Funk KL, Schneider JL, Nichols GA.
PMID: 25741443
BMJ Open Diabetes Res Care. 2015 Feb 24;3(1):e000062. doi: 10.1136/bmjdrc-2014-000062. eCollection 2015.

OBJECTIVE: To improve the health of people with diabetes, it is essential to identify why patients experience extended periods of poor glycemic control before therapeutic intensification.RESEARCH DESIGN AND METHODS: We surveyed 252 primary care providers at Kaiser Permanente Northwest...

Cite
LeBlanc ES, Rosales AG, Kachroo S, et al. Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes. BMJ Open Diabetes Res Care. 2015;3(1):e000062doi: 10.1136/bmjdrc-2014-000062.
LeBlanc, E. S., Rosales, A. G., Kachroo, S., Mukherjee, J., Funk, K. L., Schneider, J. L., & Nichols, G. A. (2015). Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes. BMJ open diabetes research & care, 3(1), e000062. https://doi.org/10.1136/bmjdrc-2014-000062
LeBlanc, Erin S, et al. "Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes." BMJ open diabetes research & care vol. 3,1 (2015): e000062. doi: https://doi.org/10.1136/bmjdrc-2014-000062
LeBlanc ES, Rosales AG, Kachroo S, Mukherjee J, Funk KL, Schneider JL, Nichols GA. Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes. BMJ Open Diabetes Res Care. 2015 Feb 24;3(1):e000062. doi: 10.1136/bmjdrc-2014-000062. eCollection 2015. PMID: 25741443; PMCID: PMC4342519.
Copy Download .nbib Format: NLM
Decreasing the cancer burden in developing countries: concerns and recommendations.

European journal of cancer care

Kachroo S, Etzel CJ.
PMID: 19473221
Eur J Cancer Care (Engl). 2009 Jan;18(1):18-21. doi: 10.1111/j.1365-2354.2008.00985.x.

Although the close of the 20th century witnessed advances in cancer detection and treatment, cancer morbidity and mortality rates steadily increase across the globe within the 21st century. The majority of this cancer burden can be found in underdeveloped...

Cite
Kachroo S, Etzel CJ. Decreasing the cancer burden in developing countries: concerns and recommendations. Eur J Cancer Care (Engl). 2009;18(1):18-21doi: 10.1111/j.1365-2354.2008.00985.x.
Kachroo, S., & Etzel, C. J. (2009). Decreasing the cancer burden in developing countries: concerns and recommendations. European journal of cancer care, 18(1), 18-21. https://doi.org/10.1111/j.1365-2354.2008.00985.x
Kachroo, S, and Etzel, C J. "Decreasing the cancer burden in developing countries: concerns and recommendations." European journal of cancer care vol. 18,1 (2009): 18-21. doi: https://doi.org/10.1111/j.1365-2354.2008.00985.x
Kachroo S, Etzel CJ. Decreasing the cancer burden in developing countries: concerns and recommendations. Eur J Cancer Care (Engl). 2009 Jan;18(1):18-21. doi: 10.1111/j.1365-2354.2008.00985.x. PMID: 19473221.
Copy Download .nbib Format: NLM
Traumatic extradural hematoma - role of non-surgical management and reasons for conversion.

The Indian journal of surgery

Bhau KS, Bhau SS, Dhar S, Kachroo SL, Babu ML, Chrungoo RK.
PMID: 23133222
Indian J Surg. 2010 Apr;72(2):124-9. doi: 10.1007/s12262-010-0036-1. Epub 2010 Jul 01.

BACKGROUND: To study the role of conservative management and various reasons for conversion to surgical intervention in traumatic extradural hematoma (EDH).SETTING: Government Medical College Jammu.MATERIALS AND METHODS: One hundred-twenty trauma patients diagnosed as extradural hematoma on CT scan were...

Cite
Bhau KS, Bhau SS, Dhar S, et al. Traumatic extradural hematoma - role of non-surgical management and reasons for conversion. Indian J Surg. 2010;72(2):124-9doi: 10.1007/s12262-010-0036-1.
Bhau, K. S., Bhau, S. S., Dhar, S., Kachroo, S. L., Babu, M. L., & Chrungoo, R. K. (2010). Traumatic extradural hematoma - role of non-surgical management and reasons for conversion. The Indian journal of surgery, 72(2), 124-9. https://doi.org/10.1007/s12262-010-0036-1
Bhau, Kulwant Singh, et al. "Traumatic extradural hematoma - role of non-surgical management and reasons for conversion." The Indian journal of surgery vol. 72,2 (2010): 124-9. doi: https://doi.org/10.1007/s12262-010-0036-1
Bhau KS, Bhau SS, Dhar S, Kachroo SL, Babu ML, Chrungoo RK. Traumatic extradural hematoma - role of non-surgical management and reasons for conversion. Indian J Surg. 2010 Apr;72(2):124-9. doi: 10.1007/s12262-010-0036-1. Epub 2010 Jul 01. PMID: 23133222; PMCID: PMC3452499.
Copy Download .nbib Format: NLM
Multiplicities in 16O-induced violent heavy-ion collisions from 5A to 2 x 10(5)A MeV.

Physical review letters

Adamovich MI, Aggarwal MM, Alexandrov YA, Andreeva NP, Anson ZV, Arora R, Badyal SK, Basova ES, Bhalla KB, Bhasin A, Bhatia VS, Bogdanov VG, Bubnov VI, Burnett TH, Cai X, Chasnikov IY, Chernova LP, Chernyavski MM, Eligbaeva GZ, Eremenko LE, Gaitinov AS, Ganssauge ER, Garpman S, Gerassimov SG, Grote J, Gulamov KG, Gupta SK, Heckman HH, Huang H, Jakobsson B, Judek B, Kachroo S, Kadyrov FG, Kalyachina GS, Kanygina EK, Karlsson L, Kaul GL, Kharlamov SP, Koss T, Kumar V, Lal P, Larionova VG, Lepetan VN, Liu LS, Lokanathan S, Lord J, Lukicheva S, Luo SB, Mangotra LK, Maslennikova NV, Mittra IS, Mokerjee S, Monnand E, Nasrullaeva H, Nasyrov SH, Navotny VS, Orlova GI, Otterlund I, Palsania HS, Peresadko NG, Petrov NV, Plyushchev VA, Qian WY, Raniwala R.
PMID: 10044086
Phys Rev Lett. 1991 Sep 02;67(10):1201-1205. doi: 10.1103/PhysRevLett.67.1201.

No abstract available.

Cite
Adamovich MI, Aggarwal MM, Alexandrov YA, et al. Multiplicities in 16O-induced violent heavy-ion collisions from 5A to 2 x 10(5)A MeV. Phys Rev Lett. 1991;67(10):1201-1205doi: 10.1103/PhysRevLett.67.1201.
Adamovich, M. I., Aggarwal, M. M., Alexandrov, Y. A., Andreeva, N. P., Anson, Z. V., Arora, R., Badyal, S. K., Basova, E. S., Bhalla, K. B., Bhasin, A., Bhatia, V. S., Bogdanov, V. G., Bubnov, V. I., Burnett, T. H., Cai, X., Chasnikov, I. Y., Chernova, L. P., Chernyavski, M. M., Eligbaeva, G. Z., Eremenko, L. E., Gaitinov, A. S., Ganssauge, E. R., Garpman, S., Gerassimov, S. G., Grote, J., Gulamov, K. G., Gupta, S. K., Heckman, H. H., Huang, H., Jakobsson, B., Judek, B., Kachroo, S., Kadyrov, F. G., Kalyachina, G. S., Kanygina, E. K., Karlsson, L., Kaul, G. L., Kharlamov, S. P., Koss, T., Kumar, V., Lal, P., Larionova, V. G., Lepetan, V. N., Liu, L. S., Lokanathan, S., Lord, J., Lukicheva, S., Luo, S. B., Mangotra, L. K., Maslennikova, N. V., Mittra, I. S., Mokerjee, S., Monnand, E., Nasrullaeva, H., Nasyrov, S. H., Navotny, V. S., Orlova, G. I., Otterlund, I., Palsania, H. S., Peresadko, N. G., Petrov, N. V., Plyushchev, V. A., Qian, W. Y., & Raniwala, R. (1991). Multiplicities in 16O-induced violent heavy-ion collisions from 5A to 2 x 10(5)A MeV. Physical review letters, 67(10), 1201-1205. https://doi.org/10.1103/PhysRevLett.67.1201
Adamovich, et al. "Multiplicities in 16O-induced violent heavy-ion collisions from 5A to 2 x 10(5)A MeV." Physical review letters vol. 67,10 (1991): 1201-1205. doi: https://doi.org/10.1103/PhysRevLett.67.1201
Adamovich MI, Aggarwal MM, Alexandrov YA, Andreeva NP, Anson ZV, Arora R, Badyal SK, Basova ES, Bhalla KB, Bhasin A, Bhatia VS, Bogdanov VG, Bubnov VI, Burnett TH, Cai X, Chasnikov IY, Chernova LP, Chernyavski MM, Eligbaeva GZ, Eremenko LE, Gaitinov AS, Ganssauge ER, Garpman S, Gerassimov SG, Grote J, Gulamov KG, Gupta SK, Heckman HH, Huang H, Jakobsson B, Judek B, Kachroo S, Kadyrov FG, Kalyachina GS, Kanygina EK, Karlsson L, Kaul GL, Kharlamov SP, Koss T, Kumar V, Lal P, Larionova VG, Lepetan VN, Liu LS, Lokanathan S, Lord J, Lukicheva S, Luo SB, Mangotra LK, Maslennikova NV, Mittra IS, Mokerjee S, Monnand E, Nasrullaeva H, Nasyrov SH, Navotny VS, Orlova GI, Otterlund I, Palsania HS, Peresadko NG, Petrov NV, Plyushchev VA, Qian WY, Raniwala R. Multiplicities in 16O-induced violent heavy-ion collisions from 5A to 2 x 10(5)A MeV. Phys Rev Lett. 1991 Sep 02;67(10):1201-1205. doi: 10.1103/PhysRevLett.67.1201. PMID: 10044086.
Copy Download .nbib Format: NLM
Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach.

Rheumatology and therapy

O'Shea F, Taylor PC, Dickie G, Yaworsky A, Banderas B, Kachroo S.
PMID: 29616498
Rheumatol Ther. 2018 Jun;5(1):87-98. doi: 10.1007/s40744-018-0107-5. Epub 2018 Apr 03.

INTRODUCTION: To establish clinical consensus on important and relevant quality-of-care (QoC) attributes in rheumatic disease (RD) treatment that may improve treatment outcomes and guide best practices.METHODS: Twenty-three QoC attributes were identified in a literature review. Fifteen European-based clinicians were...

Cite
O'Shea F, Taylor PC, Dickie G, et al. Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach. Rheumatol Ther. 2018;5(1):87-98doi: 10.1007/s40744-018-0107-5.
O'Shea, F., Taylor, P. C., Dickie, G., Yaworsky, A., Banderas, B., & Kachroo, S. (2018). Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach. Rheumatology and therapy, 5(1), 87-98. https://doi.org/10.1007/s40744-018-0107-5
O'Shea, Finbar, et al. "Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach." Rheumatology and therapy vol. 5,1 (2018): 87-98. doi: https://doi.org/10.1007/s40744-018-0107-5
O'Shea F, Taylor PC, Dickie G, Yaworsky A, Banderas B, Kachroo S. Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach. Rheumatol Ther. 2018 Jun;5(1):87-98. doi: 10.1007/s40744-018-0107-5. Epub 2018 Apr 03. PMID: 29616498; PMCID: PMC5935620.
Copy Download .nbib Format: NLM
Withdrawn as Duplicate: The many nuanced evolutionary consequences of duplicated genes.

Molecular biology and evolution

Teufel AI, Johnson MM, Laurent JM, Kachroo AH, Marcotte EM, Wilke CO.
PMID: 30445614
Mol Biol Evol. 2018 Dec 01;35(12):e1. doi: 10.1093/molbev/msy216.

No abstract available.

Cite
Teufel AI, Johnson MM, Laurent JM, et al. Withdrawn as Duplicate: The many nuanced evolutionary consequences of duplicated genes. Mol Biol Evol. 2018;35(12):e1doi: 10.1093/molbev/msy216.
Teufel, A. I., Johnson, M. M., Laurent, J. M., Kachroo, A. H., Marcotte, E. M., & Wilke, C. O. (2018). Withdrawn as Duplicate: The many nuanced evolutionary consequences of duplicated genes. Molecular biology and evolution, 35(12), e1. https://doi.org/10.1093/molbev/msy216
Teufel, Ashley I, et al. "Withdrawn as Duplicate: The many nuanced evolutionary consequences of duplicated genes." Molecular biology and evolution vol. 35,12 (2018): e1. doi: https://doi.org/10.1093/molbev/msy216
Teufel AI, Johnson MM, Laurent JM, Kachroo AH, Marcotte EM, Wilke CO. Withdrawn as Duplicate: The many nuanced evolutionary consequences of duplicated genes. Mol Biol Evol. 2018 Dec 01;35(12):e1. doi: 10.1093/molbev/msy216. PMID: 30445614.
Copy Download .nbib Format: NLM
The impact of non-persistence on the direct and indirect costs in patients treated with subcutaneous tumour necrosis factor-alpha inhibitors in Germany.

Rheumatology (Oxford, England)

Ziegelbauer K, Kostev K, Hübinger M, Dombrowski S, Friedrichs M, Friedel H, Kachroo S.
PMID: 29660105
Rheumatology (Oxford). 2018 Jul 01;57(7):1276-1281. doi: 10.1093/rheumatology/key099.

OBJECTIVE: The goal of the present study was to estimate the treatment costs in immune-mediated rheumatic disease patients initiating treatment with an s.c. biologic agent based on treatment persistence.METHODS: This is a retrospective cohort study based on the German...

Cite
Ziegelbauer K, Kostev K, Hübinger M, et al. The impact of non-persistence on the direct and indirect costs in patients treated with subcutaneous tumour necrosis factor-alpha inhibitors in Germany. Rheumatology (Oxford). 2018;57(7):1276-1281doi: 10.1093/rheumatology/key099.
Ziegelbauer, K., Kostev, K., Hübinger, M., Dombrowski, S., Friedrichs, M., Friedel, H., & Kachroo, S. (2018). The impact of non-persistence on the direct and indirect costs in patients treated with subcutaneous tumour necrosis factor-alpha inhibitors in Germany. Rheumatology (Oxford, England), 57(7), 1276-1281. https://doi.org/10.1093/rheumatology/key099
Ziegelbauer, Kathrin, et al. "The impact of non-persistence on the direct and indirect costs in patients treated with subcutaneous tumour necrosis factor-alpha inhibitors in Germany." Rheumatology (Oxford, England) vol. 57,7 (2018): 1276-1281. doi: https://doi.org/10.1093/rheumatology/key099
Ziegelbauer K, Kostev K, Hübinger M, Dombrowski S, Friedrichs M, Friedel H, Kachroo S. The impact of non-persistence on the direct and indirect costs in patients treated with subcutaneous tumour necrosis factor-alpha inhibitors in Germany. Rheumatology (Oxford). 2018 Jul 01;57(7):1276-1281. doi: 10.1093/rheumatology/key099. PMID: 29660105.
Copy Download .nbib Format: NLM
Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition.

mBio

Kachroo N, Lange D, Penniston KL, Stern J, Tasian G, Bajic P, Wolfe AJ, Suryavanshi M, Ticinesi A, Meschi T, Monga M, Miller AW.
PMID: 34372696
mBio. 2021 Aug 31;12(4):e0200721. doi: 10.1128/mBio.02007-21. Epub 2021 Aug 10.

To determine whether functionally relevant questions associated with the urinary or gut microbiome and urinary stone disease (USD) can be answered from metagenome-wide association studies (MWAS), we performed the most comprehensive meta-analysis of published clinical MWAS in USD to...

Cite
Kachroo N, Lange D, Penniston KL, et al. Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition. mBio. 2021;12(4):e0200721doi: 10.1128/mBio.02007-21.
Kachroo, N., Lange, D., Penniston, K. L., Stern, J., Tasian, G., Bajic, P., Wolfe, A. J., Suryavanshi, M., Ticinesi, A., Meschi, T., Monga, M., & Miller, A. W. (2021). Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition. mBio, 12(4), e0200721. https://doi.org/10.1128/mBio.02007-21
Kachroo, Naveen, et al. "Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition." mBio vol. 12,4 (2021): e0200721. doi: https://doi.org/10.1128/mBio.02007-21
Kachroo N, Lange D, Penniston KL, Stern J, Tasian G, Bajic P, Wolfe AJ, Suryavanshi M, Ticinesi A, Meschi T, Monga M, Miller AW. Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition. mBio. 2021 Aug 31;12(4):e0200721. doi: 10.1128/mBio.02007-21. Epub 2021 Aug 10. PMID: 34372696; PMCID: PMC8406293.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 113 entries